ImmuCell
ICCC
31 hedge funds and large institutions have $5.32M invested in ImmuCell in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
3% more funds holding
Funds holding: 30 → 31 (+1)
0.02% more ownership
Funds ownership: 13.64% → 13.65% (+0.02%)
2% less capital invested
Capital invested by funds: $5.42M → $5.32M (-$103K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$87.6K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$39.1K |
| 3 |
HPC
HM Payson & Co
Portland,
Maine
|
+$20.5K |
| 4 |
Morgan Stanley
New York
|
+$18.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
-$72.7K |
| 2 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
-$61.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$29.4K |
| 4 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$13.6K |
| 5 |
Renaissance Technologies
New York
|
-$2.24K |
ICCC Hedge Fund Activity: Q2 2023 in Review
31 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2023, worth a combined $5.32M — down 1.9% from $5.42M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ICCC positions and 3 closed out — a net gain of 1 holder — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $87.6K. The largest seller was Flagship Harbor Advisors, exiting entirely with an estimated $72.7K sold.
- 31 institutional investors held ImmuCell (ICCC) as of Q2 2023, up from 30 in Q1 2023.
- Funds reported $5.32M of ImmuCell stock for Q2 2023, down 1.9% quarter-over-quarter.
- 4 funds opened new ImmuCell positions in Q2 2023 and 3 closed out, a net change of +1 holder.
- The largest ImmuCell buyer in Q2 2023 was Susquehanna International Group, an estimated $87.6K added.
- The largest ImmuCell seller in Q2 2023 was Flagship Harbor Advisors, an estimated $72.7K sold.
Based on aggregated 13F filings for Q2 2023.